Literature DB >> 12416867

Serum fructosamine concentrations in dogs with hypothyroidism.

C E Reusch1, B Gerber, F S Boretti.   

Abstract

Serum fructosamine concentrations were measured in 11 untreated hypothyroid dogs with normal serum glucose and serum protein concentrations. The fructosamine level ranged between 276 and 441 micromol/L (median 376 micromol/L; reference range 207-340 micromol/L). Nine of the 11 dogs had fructosamine levels above the reference range. The fructosamine levels decreased significantly during treatment with levothyroxine. It is suggested that serum fructosamine concentrations may be high in hypothyroid dogs because of decelerated protein turnover, independent of the blood glucose concentration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416867     DOI: 10.1023/a:1020287430949

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  19 in total

1.  Evaluation of fructosamine in dogs and cats with hypo- or hyperproteinaemia, azotaemia, hyperlipidaemia and hyperbilirubinaemia.

Authors:  C E Reusch; B Haberer
Journal:  Vet Rec       Date:  2001-03-24       Impact factor: 2.695

2.  An evaluation of serum fructosamine as a marker of the duration of hypoproteinaemic conditions in dogs.

Authors:  S I Thoresen; W P Bredal
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

3.  Clinical value of fructosamine measurements in non-healthy dogs.

Authors:  A Loste; M C Marca; M Pérez; A Unzueta
Journal:  Vet Res Commun       Date:  2001-02       Impact factor: 2.459

4.  Serum fructosamine and thyroid function.

Authors:  D Lloyd; J Marples
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

5.  Serum fructosamine in patients with overt and treated thyroid disease.

Authors:  M J Waterson; R J Mills
Journal:  Ann Clin Biochem       Date:  1988-09       Impact factor: 2.057

6.  Study of the effect of total serum protein and albumin concentrations on canine fructosamine concentration.

Authors:  A Loste; M C Marca
Journal:  Can J Vet Res       Date:  1999-04       Impact factor: 1.310

7.  Serum fructosamine in assessment of diabetic control and relation to thyroid function.

Authors:  Y Sako; F Umeda; T Hashimoto; M Haji; H Nawata
Journal:  Horm Metab Res       Date:  1989-12       Impact factor: 2.936

8.  Fructosamine measurement in ponies: validation and response following experimental cyathostome infection.

Authors:  D Murphy; S W Reid; P A Graham; S Love
Journal:  Res Vet Sci       Date:  1997 Sep-Oct       Impact factor: 2.534

9.  Relation of fructosamine to serum protein, albumin, and glucose concentrations in healthy and diabetic dogs.

Authors:  M Kawamoto; J J Kaneko; A A Heusner; E C Feldman; I Koizumi
Journal:  Am J Vet Res       Date:  1992-05       Impact factor: 1.156

10.  Various protein and albumin corrections of the serum fructosamine concentration in the diagnosis of canine diabetes mellitus.

Authors:  A L Jensen
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

View more
  4 in total

1.  Evaluation of a human glycated hemoglobin test in canine diabetes mellitus.

Authors:  Na-Yon Kim; Jaehoon An; Jae-Kyung Jeong; Sumin Ji; Sung-Hyun Hwang; Hong-Seok Lee; Myung-Chul Kim; Hyun-Wook Kim; Sungho Won; Yongbaek Kim
Journal:  J Vet Diagn Invest       Date:  2019-02-18       Impact factor: 1.279

2.  Elevated fructosamine concentrations caused by IgA paraproteinemia in two dogs.

Authors:  Florian Zeugswetter; Miriam Kleiter; Birgitt Wolfesberger; Ilse Schwendenwein; Ingrid Miller
Journal:  J Vet Sci       Date:  2010-12       Impact factor: 1.672

3.  Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference.

Authors:  Nivedita Nanda; Zachariah Bobby; Abdoul Hamide
Journal:  Clin Exp Med       Date:  2008-07-11       Impact factor: 3.984

4.  Relationship between HbA1c, fructosamine and clinical assessment of glycemic control in dogs.

Authors:  Olga Norris; Thomas Schermerhorn
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.